Clement K. Chan: Clinical Trials

1 trial sponsored by Clement K. Chan, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow Clement K. Chan: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ranibizumab for Treating Submacular Vascularized Pigment Epithelial Detachments
Ranibizumab - Retinal Pigment Epithelial Detachment
Phase 1CompletedClement K. Chan402008-09-012012-10-05

Conditions studied

Choroidal Neovascularization (1)  ·  Neovascularization, Pathologic (1)  ·  Retinal Detachment (1)

Interventions

Ranibizumab (1)

Countries

United States (1)

Top investigators

Clement K Chan, M.D. (1)

Results publications

PMID 25277305